A new research paper was recently published in Volume 17 of Genes & Cancer, titled "Active Beta-Catenin (ABC) promotes an ...

Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior ...

Inside our bones, an extraordinary process is taking place every moment of every day. Deep within the soft tissue known as ...

Large-scale analysis of patient cohorts reveals a novel mechanism driving osteosarcoma, an aggressive paediatric bone cancer. The researchers show that this mechanism occurs in approximately 50% of ...

Oct 23 (Reuters) - Inhibrx Biosciences (INBX.O), opens new tab said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its ...

A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield. Cancer that starts in the bones, ...

The CCTG BR.34 trial was a randomized phase II study assessing durvalumab plus tremelimumab, with or without platinum-doublet chemotherapy, in 301 patients with metastatic NSCLC. Patients were ...

Even though I have a degree in biology, I knew little about cancer – until life gave me a crash course. In 2019, while working on my master’s degree in Huntsville, I developed severe leg pain. At ...

SUZETRIGINE showed limited benefit for cancer-related bone pain in three patients with metastatic spinal disease.